Deep Track Capital Increases Stake in Geron Corp to 4.95%

On May 15, 2026, Deep Track Capital, LP, alongside Deep Track Biotechnology Master Fund, Ltd. and David Kroin, filed a Schedule 13G/A with the SEC regarding their holdings in Geron Corp (GERN). The filing indicates that as of March 31, 2026, the reporting persons collectively beneficially own 31,720,278 shares of Common Stock, representing 4.95% of the class based on 640,544,661 shares outstanding. This represents an increase from a previously reported 0.0% position, though the filing also notes that the reporting persons now own 5% or less of the class of securities. David Kroin, as the Managing Member of the General Partner of the Investment Adviser and Director of the Master Fund, shared voting and dispositive power over the reported shares. The shares were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The principal executive offices of Geron Corp are located in Foster City, California.